Actor
Synthena AG
Develops first in class drugs in the field of Myopathy with a focus on the Duchenne Muscular Dystrophy disease, based on its proprietary tricyclo-DNA technology.
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.05 Gene Therapy
Business model
1. Entreprise
1.3 SME
Organization Type
Private Company
Visit website
Domains
Genetic Disease, Musculoskeletal & Inflammation
Main sector
Biotech
Contact
Freiestrasse 3
3012 Bern / BE
+41(0) 31 631 4265